BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD 2.600
-0.080 (-2.99%)
Dec 1, 2025, 2:26 PM EST
BioRem Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 34.73 | 37.42 | 25.17 | 28.86 | 24.48 | 24.38 | Upgrade | |
Revenue Growth (YoY) | -13.85% | 48.69% | -12.81% | 17.91% | 0.42% | 18.05% | Upgrade |
Cost of Revenue | 26.31 | 27.36 | 18.14 | 20.1 | 18.24 | 17.36 | Upgrade |
Gross Profit | 8.42 | 10.06 | 7.02 | 8.76 | 6.24 | 7.02 | Upgrade |
Selling, General & Admin | 5.32 | 5.62 | 3.91 | 5.79 | 3.91 | 4.77 | Upgrade |
Research & Development | 0.09 | 0.04 | 0.03 | 0.1 | 0.01 | 0.03 | Upgrade |
Other Operating Expenses | -0.11 | - | - | 0 | -0.03 | -0.05 | Upgrade |
Operating Expenses | 5.29 | 5.66 | 3.94 | 5.88 | 3.9 | 4.75 | Upgrade |
Operating Income | 3.14 | 4.39 | 3.09 | 2.88 | 2.33 | 2.27 | Upgrade |
Interest Expense | -0.17 | -0.19 | -0.27 | -0.26 | -0.04 | -0.04 | Upgrade |
Currency Exchange Gain (Loss) | -0.09 | -0.05 | -0.02 | -0.24 | -0.26 | 0.16 | Upgrade |
Other Non Operating Income (Expenses) | -0 | -0 | - | - | - | - | Upgrade |
EBT Excluding Unusual Items | 2.88 | 4.15 | 2.79 | 2.38 | 2.03 | 2.38 | Upgrade |
Other Unusual Items | - | - | - | - | - | 0.3 | Upgrade |
Pretax Income | 2.88 | 4.15 | 2.79 | 2.38 | 2.03 | 2.68 | Upgrade |
Income Tax Expense | 0.77 | 1.1 | 0.61 | 0.77 | 0.74 | 0.59 | Upgrade |
Net Income | 2.11 | 3.04 | 2.18 | 1.61 | 1.3 | 2.09 | Upgrade |
Net Income to Common | 2.11 | 3.04 | 2.18 | 1.61 | 1.3 | 2.09 | Upgrade |
Net Income Growth | -59.42% | 39.66% | 35.11% | 24.34% | -37.89% | - | Upgrade |
Shares Outstanding (Basic) | 16 | 16 | 16 | 15 | 36 | 39 | Upgrade |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 18 | 37 | 40 | Upgrade |
Shares Change (YoY) | -3.61% | 0.59% | -10.72% | -53.08% | -5.32% | 2.20% | Upgrade |
EPS (Basic) | 0.13 | 0.19 | 0.14 | 0.10 | 0.04 | 0.05 | Upgrade |
EPS (Diluted) | 0.10 | 0.16 | 0.13 | 0.09 | 0.04 | 0.05 | Upgrade |
EPS Growth | -68.00% | 23.08% | 44.45% | 149.20% | -27.77% | - | Upgrade |
Free Cash Flow | 2.23 | 3.31 | -0.06 | 1.24 | 3.71 | 3 | Upgrade |
Free Cash Flow Per Share | 0.14 | 0.21 | -0.00 | 0.07 | 0.10 | 0.08 | Upgrade |
Gross Margin | 24.25% | 26.87% | 27.90% | 30.36% | 25.48% | 28.79% | Upgrade |
Operating Margin | 9.03% | 11.74% | 12.26% | 9.97% | 9.54% | 9.29% | Upgrade |
Profit Margin | 6.08% | 8.13% | 8.66% | 5.59% | 5.30% | 8.57% | Upgrade |
Free Cash Flow Margin | 6.41% | 8.85% | -0.25% | 4.30% | 15.14% | 12.31% | Upgrade |
EBITDA | 3.46 | 4.67 | 3.28 | 3 | 2.49 | 2.38 | Upgrade |
EBITDA Margin | 9.96% | 12.49% | 13.03% | 10.38% | 10.16% | 9.78% | Upgrade |
D&A For EBITDA | 0.32 | 0.28 | 0.19 | 0.12 | 0.15 | 0.12 | Upgrade |
EBIT | 3.14 | 4.39 | 3.09 | 2.88 | 2.33 | 2.27 | Upgrade |
EBIT Margin | 9.03% | 11.74% | 12.26% | 9.97% | 9.54% | 9.29% | Upgrade |
Effective Tax Rate | 26.69% | 26.63% | 21.86% | 32.32% | 36.23% | 21.92% | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.